A Ladenburg Thalmann report reviewed the study design and purpose. In March 11 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Viveve Medical Inc. (VIVE:NASDAQ) finished enrollment for the VIVEVE II trial of 250 patients across 19 clinical locati...
Streetwise Reports
|
March 18, 2019
|
“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson
|
July 2, 2024
|
Rudi Fronk and Jim Anthony, cofounders of Seabridge Gold, discuss recession, central bank panic and an outrageous gold price. In our view, gold investors should settle back with some popcorn and enjoy the coming fireworks, which will include the best gold bull market ...
Streetwise Reports
|
October 3, 2019
|
Online brokerage house E*Trade Financial Corporation ( NASDAQ: ETFC , Stock Forum ) announced on Friday that Chief Financial Officer Bruce Nolop will step down from his post at the end of the year. Nolop, who has served as CFO since 2008, will be succeeded by Matthew Aude...
Elizabeth Harrow
|
October 28, 2012
|
The company's most advanced assets are discussed in a Dawson James Securities report. In a July 18 research note, Dawson James Securities analyst Jason Kolbert reported he assumed coverage on Daré Bioscience Inc. (DARE:NASDAQ) , and in doing so, rated it Bu...
Streetwise Reports
|
July 24, 2019
|
The benefits and terms of the agreement are outlined in a Ladenburg Thalmann report. In a Sept. 18 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Aytu BioScience Inc. (AYTU:NASDAQ) signed a definitive agreement to acquire Innovus Pharmaceutic...
Streetwise Reports
|
September 25, 2019
|
The company's latest achievement and partnership potential are addressed in a ROTH Capital Partners report. In a Dec. 12 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Daré Bioscience Inc. (DARE:NASDAQ) received U.S. Food and Drug Adminis...
Streetwise Reports
|
December 19, 2019
|
Last week, the House voted to impeach Donald Trump. This is the third time in the U.S. history such an event has happened to the sitting President. What does it imply for the gold market? Trump’s Impeachment, Explained On Wednesday, the House of Represe...
Arkadiusz Sieron
|
December 27, 2019
|
Details of the arrangement and an update on the company's pipeline are provided in a Dawson James report. In a Jan. 13 research note, Dawson James Securities analyst Jason Kolbert reported that Daré Bioscience Inc. (DARE:NASDAQ) partnered with Bayer, the company beh...
Streetwise Reports
|
January 16, 2020
|
Chinese stocks were in focus on Monday, after a surprise rate hike out of Beijing. As a result, options players swarmed the shares of Yingli Green Energy ( NYSE: YGE , Stock Forum ), with speculators revealing a preference for front-month, out-of-the-money strikes. By M...
Andrea Kramer
|
October 28, 2012
|